From breast cancer cell homing to the onset of early bone metastasis: The role of bone (re)modeling in early lesion formation.


Journal

Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440

Informations de publication

Date de publication:
23 Feb 2024
Historique:
medline: 21 2 2024
pubmed: 21 2 2024
entrez: 21 2 2024
Statut: ppublish

Résumé

Breast cancer often metastasizes to bone, causing osteolytic lesions. Structural and biophysical changes are rarely studied yet are hypothesized to influence metastasis. We developed a mouse model of early bone metastasis and multimodal imaging to quantify cancer cell homing, bone (re)modeling, and onset of metastasis. Using tissue clearing and three-dimensional (3D) light sheet fluorescence microscopy, we located enhanced green fluorescent protein-positive cancer cells and small clusters in intact bones and quantified their size and spatial distribution. We detected early bone lesions using in vivo microcomputed tomography (microCT)-based time-lapse morphometry and revealed altered bone (re)modeling in the absence of detectable lesions. With a new microCT image analysis tool, we tracked the growth of early lesions over time. We showed that cancer cells home in all bone compartments, while osteolytic lesions are only detected in the metaphysis, a region of high (re)modeling. Our study suggests that higher rates of (re)modeling act as a driver of lesion formation during early metastasis.

Identifiants

pubmed: 38381833
doi: 10.1126/sciadv.adj0975
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

eadj0975

Auteurs

Sarah A E Young (SAE)

Department of Biomaterials, Max Planck Institute of Colloids and Interfaces, Potsdam, Germany.

Anna-Dorothea Heller (AD)

Department of Biomaterials, Max Planck Institute of Colloids and Interfaces, Potsdam, Germany.

Daniela S Garske (DS)

Department of Biomaterials, Max Planck Institute of Colloids and Interfaces, Potsdam, Germany.

Maximilian Rummler (M)

Department of Biomaterials, Max Planck Institute of Colloids and Interfaces, Potsdam, Germany.
Research Centre, Shriners Hospital for Children-Canada, Faculty of Dental Medicine and Oral Health Sciences, McGill University, Montreal, Canada.

Victoria Qian (V)

Department of Biomaterials, Max Planck Institute of Colloids and Interfaces, Potsdam, Germany.

Agnes Ellinghaus (A)

Julius Wolff Institute, Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Germany.

Georg N Duda (GN)

Julius Wolff Institute, Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Germany.

Bettina M Willie (BM)

Research Centre, Shriners Hospital for Children-Canada, Faculty of Dental Medicine and Oral Health Sciences, McGill University, Montreal, Canada.

Anika Grüneboom (A)

Leibniz-Institute for Advancing Analytics - ISAS - e.V., Dortmund, Germany.

Amaia Cipitria (A)

Department of Biomaterials, Max Planck Institute of Colloids and Interfaces, Potsdam, Germany.
Group of Bioengineering in Regeneration and Cancer, Biodonostia Health Research Institute, San Sebastian, Spain.
IKERBASQUE, Basque Foundation for Science, Bilbao, Spain.

Classifications MeSH